Treatment of pulmonary infection with Penicillium marneffei involved by clinical pharmacist:1 case report

Yongli GU,Xiaofen YE,Meiling JIN,Yingyun CAI,Qianzhou LV
2016-01-01
Abstract:A 63-year-old man was hospitalized due to cough, fever and swollen lymph nodes for more than a month. According to the results of pathological lymph node biopsy, lung infection with Penicillium marneffei was clearly diagnosed. The pathogenic condition was serious with strong systemic inlfammatory response and the infection was involved in his heart. Antifungal therapy with itraconazole injection was immediately administered. However, in the 19th day of treatment, the clinician replaced itraconazole injection with itraconazole capsules for sequential treatment. Considering the patient’s condition and the low bioavailability of itraconazole oral capsule, clinical pharmacist suggested that the patient should continue itraconazole intravenous injection to control the disease and switch to itraconazole oral solution for sequential treatment after the patient condition was stable. The clinician adopted this suggestion and continued itraconazole intravenous injection. A week later, the patient’s condition was relatively stable and discharged. Three weeks later, the patient followed up in the outpatient and his condition was further improved without adverse drug reactions.
What problem does this paper attempt to address?